News for Healthier Living
Protecting Infants Before Birth: New Evidence Reshapes RSV Prevention Strategies
 Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly during the first month of life, due to immature immune defenses. Previous studies show that immunoprevention strategies targeting pregnancy and early infancy can substantially reduce RSV-related hospitalizations and severe disease. Maternal vaccination during late pregnancy enables the transfer of protective antibodies to newborns, while long-acting monoclonal antibodies administered directly to infants provide sustained protection across the RSV season. Together, these approaches offer complementary and highly effective tools to close the vulnerability gap in early life, reducing disease burden, easing pressure on healthcare systems, and improving infant survival outcomes in both high- and middle-income settings.
January 5, 2026
January 7 2026January 6 2026 - DeepCodon: A Rare-Codon-Aware AI Tool Boosts Protein Expression in E. Coli
- Engineered Probiotics Emerge as Programmable Living Medicines for Complex Diseases
- Renowned UNC Pediatric Biochemical Geneticist Leads First Study on a Novel Treatment for Hunter Syndrome
- High Levels of Chagas Disease Parasite Found in Bugs Near U.S.-Mexico Border
- AI-Powered ECG Analysis Offers Promising Path for Early Detection of Chronic Obstructive Pulmonary Disease, Says Mount Sinai Researchers
- Espervita's EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication
- Neutrophil-to-Lymphocyte Ratio May Aid Risk Stratification in Depressive Disorder
- Engineered RNA Sensor Detects and Fights Coronavirus Inside Living Cells
- Advances in Maternal-Fetal and Neonatal Diagnostics Highlighted in Special January Issue of ADLM's Clinical Chemistry Journal
- Can Taking CBD Help People Smoke Less Weed?
- Noninvasive Prenatal Screening Could Prevent Permanent Hearing Loss in Newborns
- U.S. Cuts Recommended Childhood Vaccines
- Nearly 3,000 Pounds of Ground Beef Recalled for Possible E. coli
- U.S. Backs At-Home HPV Testing to Boost Cervical Cancer Screening
- Novo Nordisk Launches Daily Weight-Loss Pill to Expand GLP-1 Access
- Young Adults With IBD Face Insurance, Cost Barriers To Care, Survey Finds
- Fingerprick Blood Test Accurately Assesses Signs of Alzheimer's, Researchers Say
- Food Insecurity, Financial Struggles Increase Children's Risk of Long COVID
- Hormone Drug Helps Fight Hormone-Fueled Breast Cancer, Trial Shows
- Autism Therapy Centers Targeted By Private Equity In U.S., Study Reveals
- Teens' Smartphone Use At School Exceeds An Hour Daily, Tracking App Reveals
- First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center
- 10 Years Later, First Children's Hospital Los Angeles Patient to Receive CAR T-Cell Therapy Remains Cancer-Free
- A Repurposed Drug Duo Shows Powerful Synergy Against Liver Fibrosis
- CU Scientists Use Ultrasound to Make Tumor Treatment Easier--and Less Risky
January 5 2026January 4 2026January 3 2026January 2 2026January 1 2026December 31 2025December 30 2025December 29 2025December 28 2025December 27 2025December 26 2025December 24 2025
|
|
|
|
|